Our Mission
We reveal and treat people with underserved chronic conditions and help them care for themselves at home
What We Do
At Tactile Medical, we specialize in developing at-home therapy devices to treat lymphedema and chronic venous insufficiency.
Our approach to supporting patients living with chronic swelling combines:
- Innovative devices: Advanced pneumatic compression devices backed by clinical research offer targeted relief from swelling and related symptoms.
- Personalized care: A nationwide team of Territory Account Managers and Patient Education Consultants who ensure patients receive personalized setup, training, and follow-up.
- Comprehensive support: Reimbursement experts, patient advocates, and clinical staff streamline access and offer guidance on navigating insurance claims, condition-specific education, and more.
Our combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Not only are patients able to improve their quality of life, but our solutions help increase clinical efficacy and reduce overall healthcare costs. Discover our lymphedema solutions to learn how pneumatic compression devices like the Nimbl™ or Flexitouch® Plus system can help you.
Our Values
We are Transparent
We are Driven
We are Collaborative
We Embrace Change
We are Compassionate




Our Promise
Tactile Medical is the only company to offer clinically proven, at-home treatment options for lymphedema and chronic venous insufficiency (CVI—supported by a full continuum of care).
- Proven results: Our lymphedema products are backed by clinical research and trusted by healthcare professionals nationwide.
- Personalized support: From your first consultation to ongoing care, we ensure patients receive the guidance they need every step of the way.
- Empowering patients: Our comprehensive approach improves clinical outcomes, reduces healthcare costs, and helps individuals reclaim their independence and quality of life.